| 2016 European Guidelines on cardiovascular disease prevention in clinical practice MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ... Polish Heart Journal (Kardiologia Polska) 74 (9), 821-936, 2016 | 10344 | 2016 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. ESCNC Societies, ESCSD Group Eur Heart J 42 (34), 3227-3337, 2021 | 4490* | 2021 |
| European Society of Cardiology: cardiovascular disease statistics 2021 A Timmis, P Vardas, N Townsend, A Torbica, H Katus, D De Smedt, ... European heart journal 43 (8), 716-799, 2022 | 608 | 2022 |
| International textbook of diabetes mellitus RA DeFronzo, E Ferrannini, P Zimmet, G Alberti John Wiley & Sons, 2015 | 487 | 2015 |
| Serum levels of microRNAs in patients with heart failure Y Goren, M Kushnir, B Zafrir, S Tabak, BS Lewis, O Amir European journal of heart failure 14 (2), 147-154, 2012 | 446 | 2012 |
| Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society … B Zafrir, LH Lund, C Laroche, F Ruschitzka, MG Crespo-Leiro, AJS Coats, ... European heart journal 39 (48), 4277-4284, 2018 | 244 | 2018 |
| The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox” B Zafrir, Y Adir, W Shehadeh, M Shteinberg, N Salman, O Amir Respiratory medicine 107 (1), 139-146, 2013 | 87 | 2013 |
| A novel approach to monitoring pulmonary congestion in heart failure: initial animal and clinical experiences using remote dielectric sensing technology O Amir, D Rappaport, B Zafrir, WT Abraham Congestive Heart Failure 19 (3), 149-155, 2013 | 83 | 2013 |
| Plaque morphology as predictor of late plaque events in patients with asymptomatic type 2 diabetes: a long-term observational study DA Halon, I Lavi, O Barnett-Griness, R Rubinshtein, B Zafrir, M Azencot, ... JACC: Cardiovascular Imaging 12 (7 Part 2), 1353-1363, 2019 | 70 | 2019 |
| Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications B Zafrir, M Jain Cardiovascular drugs and therapy 28, 361-377, 2014 | 70 | 2014 |
| Therapeutic angiogenesis in critical limb ischemia GO Ouma, B Zafrir, ER Mohler III, MY Flugelman Angiology 64 (6), 466-480, 2013 | 69 | 2013 |
| Severe hypertriglyceridemia-related pancreatitis: characteristics and predictors of recurrence B Zafrir, W Saliba, A Jubran, R Hijazi, C Shapira Pancreas 48 (2), 182-186, 2019 | 61 | 2019 |
| Nonagenarians in internal medicine: characteristics, outcomes and predictors for in-hospital and post-discharge mortality B Zafrir, A Laor, H Bitterman IMAJ-Israel Medical Association Journal 12 (1), 10, 2010 | 60 | 2010 |
| Brown adipose tissue: research milestones of a potential player in human energy balance and obesity B Zafrir Hormone and Metabolic Research 45 (11), 774-785, 2013 | 58 | 2013 |
| Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation B Zafrir Journal of cardiopulmonary rehabilitation and prevention 33 (5), 263-273, 2013 | 51 | 2013 |
| Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of … B Zafrir, N Salman, MG Crespo‐Leiro, SD Anker, AJ Coats, R Ferrari, ... European journal of heart failure 18 (7), 859-868, 2016 | 48 | 2016 |
| Hypertriglyceridemia-related pancreatitis in patients with type 2 diabetes: links and risks E Shemesh, B Zafrir Diabetes, metabolic syndrome and obesity: targets and therapy, 2041-2052, 2019 | 39 | 2019 |
| Epstein-Barr virus-associated pericarditis and pericardial effusion: case report and diagnostic aspects B Zafrir, A Aviv, N Reichman, E Flatau European Journal of Internal Medicine 16 (7), 528-530, 2005 | 38 | 2005 |
| Lipid‐lowering therapy with PCSK 9‐inhibitors in the real‐world setting: Two‐year experience of a regional lipid clinic B Zafrir, A Jubran Cardiovascular Therapeutics 36 (5), e12439, 2018 | 37 | 2018 |
| Resting heart rate and measures of effort-related cardiac autonomic dysfunction predict cardiovascular events in asymptomatic type 2 diabetes B Zafrir, M Azencot, I Dobrecky-Mery, BS Lewis, MY Flugelman, DA Halon European journal of preventive cardiology 23 (12), 1298-1306, 2016 | 35 | 2016 |
